Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • National...

    Tag: national pharmaceutical pricing authority

    You Searched For "National Pharmaceutical Pricing Authority"
    Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent

    Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent

    Meghna A Singhania5 March 2019 5:01 PM IST
    New Delhi: In a major setback to Meril Lifesciences, the drug price regulator National Pharmaceutical Pricing Authority(NPPA) has refused to give it...
    NPPA revises ceiling prices of 14 drug formulations including Injections, Inhalators; Details

    NPPA revises ceiling prices of 14 drug formulations including Injections, Inhalators; Details

    Meghna A Singhania3 March 2019 10:45 AM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) revises the ceiling...
    NPPA caps trade margins to 30 percent for 42 cancer drugs

    NPPA caps trade margins to 30 percent for 42 cancer drugs

    Meghna A Singhania28 Feb 2019 9:20 AM IST
    As per data available with NPPA, the MRP for 105 brands will be reduced up to 85 per cent entailing minimum saving of Rs 105 crore to consumers, it...
    Launching product without Approval: DOP rejects Biocon Plea against NPPA action

    Launching product without Approval: DOP rejects Biocon Plea against NPPA action

    Meghna A Singhania24 Feb 2019 11:25 AM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals rejected the review applications filed by biopharmaceutical major Biocon...
    NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report

    NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report

    Meghna A Singhania21 Feb 2019 3:13 PM IST
    However, the move is likely to stimulate retailers to spend more as trade margins on drugs that have somehow bypassed the list and the retailers may...
    NPPA fixes retail price of Emcure pharma

    NPPA fixes retail price of Emcure pharma's HIV drug

    Meghna A Singhania17 Feb 2019 9:30 AM IST
    New Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Emcure...
    NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent

    NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent

    Meghna A Singhania3 Feb 2019 11:16 AM IST
    New Delhi: A Year after Abbott's launch of biodegradable stents which was later withdrawn globally, Meril Life Sciences has moved the National...
    NPPA fixes retail price of 29 drug formulations including BP, Cholesterol, pain medications; Details

    NPPA fixes retail price of 29 drug formulations including BP, Cholesterol, pain medications; Details

    Farhat Nasim30 Jan 2019 11:32 AM IST
    The NPPA order is likely to affect various drug majors including Lupin, Sun Pharmaceuticals, GlaxoSmithKline and Cadila Pharmaceuticals. New Delhi:...
    NPPA fixes retail price of 68 drug formulations, check out details

    NPPA fixes retail price of 68 drug formulations, check out details

    Medical Dialogues Bureau3 Nov 2018 11:14 AM IST
    Some of the formulations whose price has been fixed by NPPA include Clarithromycin for Oral Suspension (CIPLA), Baclofen Oral Solution ( Sun Pharma),...
    DOP rejects Review Petition of Lupin against ceiling price fixation for its combinations

    DOP rejects Review Petition of Lupin against ceiling price fixation for its combinations

    Medical Dialogues Bureau23 Sept 2018 12:39 PM IST
    Department of Pharmaceutical rejected the review petition of Lupin " Lupin has not implemented the price notification"New Delhi: Through a recent...
    Refix ceiling price of Sun Pharma

    Refix ceiling price of Sun Pharma's ciprofloxacin 250mg, 500mg tablets: DoP tells NPPA

    Ruby Khatun Khatun5 March 2018 5:48 PM IST
    The Department of Pharmaceuticals (DoP) has given its decision in favour of Sun Pharma against the price fixing of ciprofloxacin 250mg and...
    Fortis Healthcare rejects over pricing of drugs charge

    Fortis Healthcare rejects over pricing of drugs charge

    Ruby Khatun Khatun18 Dec 2017 11:00 AM IST
    New Delhi: Fortis Healthcare has rejected charges of overpricing the medicines that it is giving to its patients.In a statement, it said, "Fortis...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok